| Value | ₹49.50 Cr |
|---|
NSE filing, NSE: KANORICHEM. Summary written from the filing by ALFA Finder's alert engine.
Kanoria Chemicals & Industries Ltd: key numbers
- Share price
- ₹167.34
- Market cap
- ₹731.2 Cr
- Revenue (annual)
- ₹981.4 Cr
- Net profit (annual)
- ₹120.8 Cr
- P/E (TTM)
- 4.7×Sector 34.1×
- Promoter holding
- 74.40%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kanoria Chemicals & Industries Ltd
All →Kanoria Chemicals & Industries Other Announcement
Kanoria Chemicals & Industries Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Kanoria Chemicals & Industries Capacity Expansion
Kanoria Chemicals announced a new 12 TPD Triacetin manufacturing facility at its existing site in Ankleshwar, Gujarat, to strengthen its specialty chemicals portfolio.
- manufacturing capacity
- 12.0 TPD
Kanoria Chemicals & Industries Credit Rating
Infomerics rated Kanoria Chemicals' long-term bank facilities IVR BBB-/Stable and short-term facilities IVR A3. The rating covers a total of Rs.162.07 Crore in rated bank loan facilities.
Kanoria Chemicals & Industries Investor Presentation: Key Takeaways
Kanoria Chemicals reported strong FY26 performance with 30% consolidated revenue growth and 90% EBITDA growth. Management highlights operational efficiencies and a strategic 'Vision 2030' roadmap.
Kanoria Chemicals & Industries Annual General Meeting
Kanoria Chemicals & Industries Limited conducted its 66th Annual General Meeting on September 2, 2026, via video conferencing. The meeting covered routine ordinary and special business resolutions.
Kanoria Chemicals & Industries Q1 FY27 Results: Turns Profitable, Net Profit ₹26.4 Cr
Kanoria Chemicals & Industries Ltd reported revenue from operations of ₹460.4 Cr (+128.6% YoY) and net profit of ₹26.4 Cr for Q1 FY27.
- Key figure
- Net profit ₹26.4 Cr
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.